{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:13:10Z","timestamp":1788394390344,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T00:00:00Z","timestamp":1782000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":74,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to assess the prevalence of unsuppressed viral load and its associated factors among people living with HIV (PLWH) receiving antiretroviral therapy (ART) in the Xinjiang Production and Construction Corps (XPCC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Clinical data and questionnaires were collected from four divisions of the XPCC via random sampling. Logistic regression and mediation analyses were performed to identify factors associated with unsuppressed viral load.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 369 PLWH, 55 (14.91%) had unsuppressed viral load. Associated factors included CD4+ T-cell count\u2009\u2265\u2009500 cells\/\u03bcL, treatment duration\u2009\u2265\u20093\u2009years, alcohol consumption, discrimination, poor ART adherence, and poor self-efficacy (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). ART adherence played a full mediating role between self-efficacy, social support and unsuppressed viral load in PLWH, with a mediation effect value (a*b) of \u03b2\u2009=\u2009\u22120.010 (95% CI: \u22120.013, \u22120.006) and \u03b2\u2009=\u2009\u22120.021 (95% CI: \u22120.029, \u22120.014). Greater social support and higher self-efficacy reduce the risk of unsuppressed viral load in PLWH via improved ART adherence. Additionally, the \u201csocial support \u21d2 medication adherence\u201d pathway exerted a partial chain mediating role between self-efficacy and viral load suppression in PLWH, with a mediation effect value (a*b) of \u03b2\u2009=\u2009\u22120.012 (95% CI :-0.017, \u22120.006).Social support can first enhance patients\u2019 self-efficacy, which in turn further improves ART adherence, thereby reducing the risk of unsuppressed viral load.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In the XPCC, the viral suppression rate among PLWH has not yet met the UNAIDS 95\u201395-95 target. Priority should be given to PLWH with &lt;3\u2009years of treatment and CD4+ T-cell count\u2009&lt;\u2009500 cells\/\u03bcL. HIV-related education should be delivered to individuals, families and the public to enhance social support and self-efficacy, reduce HIV-related stigma, and promote healthy lifestyles (e.g. reduced alcohol consumption). These measures will improve adherence to ART, thereby achieving effective viral load suppression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-13842-1","type":"journal-article","created":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T15:14:44Z","timestamp":1782054884000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unsuppressed viral load and its associated factors among people living with HIV on antiretroviral therapy: a cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"given":"Bahejianati","family":"Nuerbolati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songsong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,21]]},"reference":[{"issue":"3","key":"13842_CR1","first-page":"225","volume":"31","author":"CDC China","year":"2025","unstructured":"National Center for AIDS\/STD Control and Prevention, China CDC. National AIDS STD epidemic, December 2024. Chin J AIDS STD. 2025;31(3):225.","journal-title":"Chin J AIDS STD"},{"key":"13842_CR2","unstructured":"United Nations General Assembly. Political Declaration on HIV and AIDS: ending inequalities and getting on track to end AIDS by 2030[Z]. 2021."},{"key":"13842_CR3","unstructured":"General Office of the State Council. Circular on printing and distributing the National Plan for the Prevention and Control of AIDS (2024 - 2030): document No. GBF. 2024;(51[A\/OL]. 2024 Dec 11 [cited 2024 Dec 16]. https:\/\/www.gov.cn\/zhengce\/content\/202412\/content_6992032.htm."},{"issue":"2","key":"13842_CR4","first-page":"46","volume":"20","author":"WW Yang","year":"2022","unstructured":"Yang WW, Yang DM, Xia Y, et al. Characteristics of AIDS epidemic and countermeasures for Prevention and Control in Xinjiang Production and Construction Corps, 1996-2021. J BingTuan Med. 2022;20(2):46\u201350.","journal-title":"J BingTuan Med"},{"issue":"4","key":"13842_CR5","first-page":"42","volume":"21","author":"DM Yang","year":"2023","unstructured":"Yang DM, Xia Y, Ma L, et al. Analysis of AIDS case reports in Xinjiang Production and Construction Corps from 2017 to 2022. J BingTuan Med. 2023;21(4):42\u201345.","journal-title":"J BingTuan Med"},{"key":"13842_CR6","unstructured":"Acquired Immunodeficiency Syndrome Professional Group. Society of Infectious Diseases, Chinese Medical Association; Chinese center for Disease Control and Prevention. Chinese Guidelines for Diagnosis and treatment of Human immunodeficiency virus Infection \/Acquired immunodeficiency syndrome (2024 edition)) . Med J Peking Union Med Coll Hosp. 2024;15(6):1261\u201388."},{"key":"13842_CR7","first-page":"98","volume":"2","author":"SY Xiao","year":"1994","unstructured":"Xiao SY. Theoretical basis and research applications of the social support Rating scale (SSRS) . J Clin Psychiatry. 1994;2:98\u2013100.","journal-title":"J Clin Psychiatry"},{"key":"13842_CR8","volume-title":"HIV-ASES adjustment and evaluation based on Chinese cultural background[D]","author":"SM Yang","year":"2017","unstructured":"Yang SM. HIV-ASES adjustment and evaluation based on Chinese cultural background[D]. ZHENGZHOU UNIVERSITY; 2017."},{"issue":"4","key":"13842_CR9","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/jep.12125","volume":"20","author":"J Yan","year":"2014","unstructured":"Yan J, You LM, Yang Q, Liu B, Jin S, Zhou J, et al. Translation and validation of a Chinese version of the 8-item Morisky medication adherence scale in myocardial infarction patients. Evaluation Clin Pract. 2014;20(4):311\u201317. https:\/\/doi.org\/10.1111\/jep.12125.","journal-title":"Evaluation Clin Pract"},{"issue":"2","key":"13842_CR10","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/QAI.0b013e318142aabb","volume":"46","author":"JH Samet","year":"2007","unstructured":"Samet JH, Cheng DM, Libman H, Nunes DP, Alperen JK, Saitz R. Alcohol consumption and HIV disease progression. JAIDS J Acquired Immune Deficiency Syndromes. 2007;46(2):194\u201399. https:\/\/doi.org\/10.1097\/QAI.0b013e318142aabb.","journal-title":"JAIDS J Acquired Immune Deficiency Syndromes"},{"key":"13842_CR11","unstructured":"Centers for Disease Control and Prevention (CDC). Cigarette smoking among adults-United States, 1992, and changes in the definition of current cigarette smoking. MMWR Morb Mortal Wkly Rep. 1994;43(19):342\u201346."},{"issue":"8","key":"13842_CR12","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1177\/1359105319869809","volume":"26","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Li X, Cho H, Brown MJ, Qiao S, Haider MR. Effects of individual and neighborhood socioeconomic status on antiretroviral therapy adherence: the role of adherence self-efficacy. J Health Psychol. 2021;26(8):1143\u201353. https:\/\/doi.org\/10.1177\/1359105319869809.","journal-title":"J Health Psychol"},{"issue":"1","key":"13842_CR13","doi-asserted-by":"publisher","first-page":"14763","DOI":"10.1038\/s41598-025-93608-y","volume":"15","author":"AS Tegegne","year":"2025","unstructured":"Tegegne AS. Robustness of viral load over CD4 cell count in measuring the quality of life of people with HIV at second line regimen in Amhara region. Sci Rep. 2025;15(1):14763. https:\/\/doi.org\/10.1038\/s41598-025-93608-y.","journal-title":"Sci Rep"},{"issue":"5","key":"13842_CR14","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/tmi.12079","volume":"18","author":"AT Brennan","year":"2013","unstructured":"Brennan AT, Maskew M, Sanne I, Fox MP. The interplay between CD4 cell count, viral load suppression and duration of antiretroviral therapy on mortality in a resource-limited setting. Trop Med Int Health. 2013;18(5):619\u201331. https:\/\/doi.org\/10.1111\/tmi.12079.","journal-title":"Trop Med Int Health"},{"key":"13842_CR15","doi-asserted-by":"publisher","unstructured":"Qian Y, Yang DM, Yang WW, et al. Analysis of the effectiveness of HIV antiretroviral treatment in Xinjiang Production and Construction Corps from 2019 to 2022[J].Journal of Preventive Medicine Information, 1-5[2025-04-23]. https:\/\/doi.org\/10.19971\/j.cnki. 1006-4028.240339.","DOI":"10.19971\/j.cnki"},{"issue":"1","key":"13842_CR16","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12879-023-08165-4","volume":"23","author":"D Niu","year":"2023","unstructured":"Niu D, Xiao T, Chen Y, Tang H, Chen F, Cai C, et al. Excess mortality and associated factors among people living with HIV initiating highly active antiretroviral therapy in Luzhou, China 2006\u20132020. BMC Infect Dis. 2023, Mar, 29;23(1):186. https:\/\/doi.org\/10.1186\/s12879-023-08165-4.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"13842_CR17","first-page":"382","volume":"49","author":"ZF Liu","year":"2022","unstructured":"Liu ZF, Zhang GL, He QY. Analysis of viral load of HIV\/AIDS patients after antiretroviral therapy in Dali region. Int J Epidemiol Infect Disease. 2022;49(6):382\u201385.","journal-title":"Int J Epidemiol Infect Disease"},{"issue":"11","key":"13842_CR18","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/hiv.13020","volume":"21","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Han MJ, Gan XM, Ma Y, Zhao DC. Characteristics and viral suppression among people living with HIV from the National free antiretroviral therapy programme, 2019. HIV Med. 2020;21(11):701\u201307. https:\/\/doi.org\/10.1111\/hiv.13020.","journal-title":"HIV Med"},{"issue":"11","key":"13842_CR19","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1093\/cid\/ciad177","volume":"76","author":"JA Perez-Molina","year":"2023","unstructured":"Perez-Molina JA, Crespillo-And\u00fajar C, Zamora J, Fern\u00e1ndez-F\u00e9lix BM, Gaetano-Gil A, L\u00f3pez-Bernaldo de Quir\u00f3s JC, et al. Contribution of low CD4 cell counts and High Human immunodeficiency virus (HIV) viral load to the efficacy of preferred First-line antiretroviral regimens for treating HIV Infection: a systematic Review and meta-analysis. Clin Infect Dis. 2023;76(11):2027\u201337. https:\/\/doi.org\/10.1093\/cid\/ciad177.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"13842_CR20","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/cid\/ciz214","volume":"70","author":"G Fatti","year":"2020","unstructured":"Fatti G, Grimwood A, Nachega JB, Nelson JA, LaSorda K, van Zyl G, et al. Better virological outcomes among people living with Human Immunodeficiency virus (HIV) initiating early antiretroviral treatment (CD4 counts \u2265500 Cells\/\u00b5L) in the HIV Prevention trials network 071 (PopART) trial in South Africa. Clin Infect Dis. 2020;70(3):395\u2013403. https:\/\/doi.org\/10.1093\/cid\/ciz214.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"13842_CR21","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1097\/QAD.0000000000004205","volume":"39","author":"JS van der Mannen","year":"2025","unstructured":"van der Mannen JS, Furamera S, Pienaar J, Komane P, Shokota L, Ramashala B, et al. Predictors of unsuppressed viral load among MSM with HIV in South Africa. AIDS. 2025;39(9):1290\u201396. https:\/\/doi.org\/10.1097\/QAD.0000000000004205.","journal-title":"AIDS"},{"issue":"10","key":"13842_CR22","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1111\/acer.13204","volume":"40","author":"EC Williams","year":"2016","unstructured":"Williams EC, Hahn JA, Saitz R, Bryant K, Lira MC, Samet JH. Alcohol use and Human immunodeficiency virus (HIV) Infection: current knowledge, implications, and future Directions. Alcohol Clin Exp Res. 2016;40(10):2056\u201372. https:\/\/doi.org\/10.1111\/acer.13204.","journal-title":"Alcohol Clin Exp Res"},{"key":"13842_CR23","doi-asserted-by":"publisher","unstructured":"Nouaman MN, Vinikoor M, Seydi M, Ekouevi DK, Coffie PA, Mulenga L, et al. High prevalence of binge drinking among people living with HIV in four African countries. J Intern AIDS Soc. 2018;21(12):e25202. https:\/\/doi.org\/10.1002\/jia2.25202.","DOI":"10.1002\/jia2.25202"},{"issue":"7","key":"13842_CR24","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1007\/s10461-024-04299-x","volume":"28","author":"A Wynn","year":"2024","unstructured":"Wynn A, Sileo KM, Schmarje Crockett K, Naigino R, Ediau M, Menzies NA, et al. Associations between alcohol use, antiretroviral therapy use, and viral load suppression among people living with HIV in rural Central Uganda. AIDS Behav. 2024;28(7):2205\u201315. https:\/\/doi.org\/10.1007\/s10461-024-04299-x.","journal-title":"AIDS Behav"},{"key":"13842_CR25","doi-asserted-by":"publisher","first-page":"100486","DOI":"10.1016\/j.abrep.2023.100486","volume":"17","author":"ER Cachay","year":"2023","unstructured":"Cachay ER, Moges TS, Qin H, Bamford L, Grelotti DJ, Mathews WC. Effects of drug and hazardous alcohol use on having a detectable HIV viral load: an adherence mediation analysis. Addictive Behaviors Rep. 2023;17:100486. https:\/\/doi.org\/10.1016\/j.abrep.2023.100486.","journal-title":"Addictive Behaviors Rep"},{"key":"13842_CR26","doi-asserted-by":"publisher","first-page":"117699","DOI":"10.1016\/j.socscimed.2025.117699","volume":"366","author":"I Yigit","year":"2025","unstructured":"Yigit I, Wilson TE, Taylor TN, Kassaye SG, Weiser SD, Cohen MH, et al. Association of experienced stigma in healthcare settings with health outcomes among black women living with HIV: mediating roles of internalized stigma, anticipated stigma, and trust in HIV care. Soc Sci Med. 2025;366:117699. https:\/\/doi.org\/10.1016\/j.socscimed.2025.117699.","journal-title":"Soc Sci Med"},{"key":"13842_CR27","doi-asserted-by":"publisher","unstructured":"Nyblade L, Mingkwan P, Stockton MA. Stigma reduction: an essential ingredient to ending AIDS by 2030. Lancet HIV. 2021;8(2):e106\u201313. https:\/\/doi.org\/10.1016\/S2352-3018(20)30309-X.","DOI":"10.1016\/S2352-3018(20)30309-X"},{"issue":"1","key":"13842_CR28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12981-025-00719-7","volume":"22","author":"B Oryokot","year":"2025","unstructured":"Oryokot B, Kazibwe A, Oluka AI, Kagimu D, Bakashaba B, Ssentongo SM, et al. \u201cSwallowing these drugs every day, you get tired\u201d: a mixed-methods study to identify barriers and facilitators to retention and HIV viral load suppression among the adolescents living with HIV in TASO Mbale and TASO Soroti centers of excellence. AIDS Res Ther. 2025;22(1):43. https:\/\/doi.org\/10.1186\/s12981-025-00719-7.","journal-title":"AIDS Res Ther"},{"key":"13842_CR29","doi-asserted-by":"publisher","unstructured":"Mukuku O, Govender K, Wembonyama SO. Barriers and facilitators to HIV viral load suppression among adolescents living with HIV in Lubumbashi, Democratic Republic of the Congo: a qualitative study. PLoS One. 2025;20(3):e0320417. https:\/\/doi.org\/10.1371\/journal.pone.0320417.","DOI":"10.1371\/journal.pone.0320417"},{"issue":"2","key":"13842_CR30","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s10461-018-2255-6","volume":"23","author":"E Umar","year":"2019","unstructured":"Umar E, Levy JA, Bailey RC, Donenberg G, Hershow RC, Mackesy-Amiti ME. Virological non-suppression and its Correlates among adolescents and Young people living with HIV in Southern Malawi. AIDS Behav. 2019;23(2):513\u201322. https:\/\/doi.org\/10.1007\/s10461-018-2255-6.","journal-title":"AIDS Behav"},{"issue":"3","key":"13842_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1089\/apc.2020.0224","volume":"35","author":"AB Spence","year":"2021","unstructured":"Spence AB, Michel K, Wang C, Dutton MA, Lee K, Merenstein D, et al. Viral suppression is associated with HIV treatment self-efficacy in a cohort of women in Washington, DC. AIDS Patient Care STDs. 2021;35(3):75\u201383. https:\/\/doi.org\/10.1089\/apc.2020.0224.","journal-title":"AIDS Patient Care STDs"},{"issue":"4","key":"13842_CR32","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/QAI.0000000000002268","volume":"83","author":"KB Crockett","year":"2020","unstructured":"Crockett KB, Entler KJ, Brodie E, Kempf M-C, Konkle-Parker D, Wilson TE, et al. Brief report: linking depressive symptoms to viral nonsuppression among women with HIV through adherence self-efficacy and ART adherence. JAIDS J Acquired Immune Deficiency Syndromes. 2020;83(4):340\u201344. https:\/\/doi.org\/10.1097\/QAI.0000000000002268.","journal-title":"JAIDS J Acquired Immune Deficiency Syndromes"},{"issue":"11","key":"13842_CR33","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1089\/apc.2020.0114","volume":"34","author":"I Yigit","year":"2020","unstructured":"Yigit I, Bayramoglu Y, Weiser SD, Johnson MO, Mugavero MJ, Turan JM, et al. Changes in internalized stigma and HIV Health outcomes in individuals New to HIV Care: the mediating roles of depression and treatment self-efficacy. AIDS Patient Care STDs. 2020;34(11):491\u201397. https:\/\/doi.org\/10.1089\/apc.2020.0114.","journal-title":"AIDS Patient Care STDs"},{"key":"13842_CR34","doi-asserted-by":"publisher","unstructured":"Mukuku O, Govender K, Wembonyama SO. Prevalence and determinants of unsuppressed HIV viral loads among children and adolescents living with HIV on antiretroviral therapy in Lubumbashi, Democratic Republic of the Congo: a retrospective cross-sectional study. BMJ Open. 2025;15(7):e094657. https:\/\/doi.org\/10.1136\/bmjopen-2024-094657.","DOI":"10.1136\/bmjopen-2024-094657"},{"issue":"5","key":"13842_CR35","first-page":"381","volume":"19","author":"CC Tian","year":"2013","unstructured":"Tian CC, Li H, Xiao YK, et al. ART adherence and related impact factors among AIDS patients. Chin J AIDS STD. 2013;19(5):381\u201384.","journal-title":"Chin J AIDS STD"},{"issue":"1","key":"13842_CR36","doi-asserted-by":"publisher","first-page":"21437","DOI":"10.7448\/IAS.20.1.21437","volume":"20","author":"MH Kim","year":"2017","unstructured":"Kim MH, Mazenga AC, Yu X, Ahmed S, Paul ME, Kazembe PN, et al. High self-reported non-adherence to antiretroviral therapy amongst adolescents living with HIV in Malawi: barriers and associated factors. J Int AIDS Soc. 2017;20(1):21437. https:\/\/doi.org\/10.7448\/IAS.20.1.21437.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"13842_CR37","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/idr13010014","volume":"13","author":"PM Nguyen","year":"2021","unstructured":"Nguyen PM, Thach AN, Pham XD, Lam AN, Nguyen TNP, Duong CX, et al. Prevalence and determinants of medication adherence among patients with HIV\/AIDS in Southern Vietnam. Infect Dis Rep. 2021;13(1):126\u201335. https:\/\/doi.org\/10.3390\/idr13010014.","journal-title":"Infect Dis Rep"},{"key":"13842_CR38","doi-asserted-by":"publisher","unstructured":"Tchakoute TC, Rhee SY, Hare CB, Shafer RW, Sainani K. Adherence to contemporary antiretroviral treatment regimens and impact on immunological and virologic outcomes in a US healthcare system. PLoS One. 2022;17(2):e0263742. https:\/\/doi.org\/10.1371\/journal.pone.0263742.","DOI":"10.1371\/journal.pone.0263742"},{"issue":"16","key":"13842_CR39","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1097\/QAD.0000000000000782","volume":"29","author":"TR Glass","year":"2015","unstructured":"Glass TR, Sterne JAC, Schneider MP, De Geest S, Nicca D, Furrer H, et al. Swiss HIV cohort study. Self-reported nonadherence to antiretroviral therapy as a predictor of viral failure and mortality. AIDS. 2015;29(16):2195\u2013200. https:\/\/doi.org\/10.1097\/QAD.0000000000000782.","journal-title":"AIDS"},{"key":"13842_CR40","doi-asserted-by":"publisher","first-page":"117643","DOI":"10.1016\/j.socscimed.2024.117643","volume":"366","author":"A Norcini-Pala","year":"2025","unstructured":"Norcini-Pala A, Stringer KL, Kempf MC, Konkle-Parker D, Wilson TE, Tien PC, et al. Longitudinal associations between intersectional stigmas, antiretroviral therapy adherence, and viral load among women living with HIV using multidimensional latent transition item response analysis. Soc Sci Med. 2025;366:117643. https:\/\/doi.org\/10.1016\/j.socscimed.2024.117643.","journal-title":"Soc Sci Med"},{"issue":"3","key":"13842_CR41","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/tmi.13854","volume":"28","author":"ACB Daltro","year":"2023","unstructured":"Daltro ACB, Almeida CS, Unfried AGC, de Aquino TR, Travassos AG\u00c1. Virological failure and adherence to antiretroviral therapy in adolescents and young adults living with human immunodeficiency virus. Trop Med Int Health. 2023;28(3):162\u201374. https:\/\/doi.org\/10.1111\/tmi.13854.","journal-title":"Trop Med Int Health"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13842-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13842-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13842-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T23:16:47Z","timestamp":1788391007000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13842-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,21]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13842"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13842-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8188770\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,21]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We certify that the study was conducted in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. The study protocol were approved by the Ethics Review Committee of the First Affiliated Hospital of Shihezi University (No.: KJ2023-311\u201301). Informed consent was obtained from all participants prior to the administration of the questionnaire.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1599"}}